Remove 2017 Remove FDA Remove Licensing
article thumbnail

EU and US Regulatory Challenges Facing AI Health Care Innovator Firms

Bill of Health

Beyond the health care sector-specific Medical Devices Regulation (EU) 2017/745 (MDR) and the In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746 (IVDR), this mix of AI & Data related regulatory requirements stems from a series of generalized, cross-sectoral EU laws of the last 5 years.

FDA 288
article thumbnail

Cybersecurity Vulnerabilities in Implantable Medical Devices

HIT Consultant

Food and Drug Administration (FDA). In 2017, the regulator warned the radio-frequency-enabled devices manufactured by St. However, as of 2023, the FDA orders they meet specific security guidelines — patches must be available periodically and in emergencies, and manufacturers must submit a software bill of materials.

FDA 115
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Federal Judge Refuses to Dismiss Florida Compounding Pharmacy’s FCA Suit

Pharmacy Law Blog

On December 4, 2017, a Florida federal judge refused to dismiss the federal government’s False Claims Act (FCA) suit against a compounding pharmacy. The firm’s attorneys include those who are board certified by The Florida Bar in Health Law as well as licensed health professionals who are also attorneys. December 4, 2017).

Fraud 52
article thumbnail

Analysis: Seeking Balance in the Hyperactive Mental Health Tech Market

HIT Consultant

Notable transactions in the consumer and member tech category include: Pear Therapeutics , software-based medicine provider, made its mark in 2017 as its tool became the first digital therapeutic approved by the FDA with claims to improve clinical outcomes.

article thumbnail

Digital Documentation: How PDFs Can Help Providers Expedite Care

HIT Consultant

In 2015, half of Americans believed renewing their driver’s license requires less paperwork than a trip to the clinic, and 29 percent of patients still had to physically transport test results, X-rays, or health records from one physician’s office to another, according to a survey conducted by Surescripts.

FDA 98
article thumbnail

Connecticut Follows in the Footsteps of Other Jurisdictions Requiring Registration of Pharmaceutical Representatives

Healthcare Law Blog

Effective January 1, 2022, an individual in Oregon who acts as a pharmaceutical representative for more than 15 days during the calendar year must have, and renew annually, a license from the Department of Consumer and Business Services (“DCBS”). viii] Chicago, Illinois. ix] Nevada.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – September/October

SQA

The EC presented a first draft for public comment to the revision of Annex 1 in 2017. Since health authorities have not yet published guidelines for a comprehensive control strategy specific to microbiological topics for ATMPs, it is up to the individual ATMP sponsor or license holder to apply these compendial references properly.

FDA 40